Sotera Health (NYSE:SHC) Cut to Hold at Zacks Investment Research

Zacks Investment Research cut shares of Sotera Health (NYSE:SHCGet Rating) from a buy rating to a hold rating in a research report sent to investors on Thursday, Zacks.com reports.

According to Zacks, “Sotera Health Company is a provider of mission-critical end-to-end sterilization solutions and lab testing as well as advisory services for the healthcare industry. The company market through businesses which include Sterigenics(R), Nordion(R) and Nelson Labs(R). Sotera Health Company is Sotera Health Company is based in CLEVELAND. “

SHC has been the subject of a number of other reports. Barclays downgraded Sotera Health from an overweight rating to an equal weight rating and set a $24.00 price objective for the company. in a research report on Wednesday, March 2nd. Jefferies Financial Group downgraded Sotera Health from a buy rating to a hold rating and lowered their price objective for the stock from $34.00 to $22.00 in a research report on Thursday, March 3rd. The Goldman Sachs Group lowered their price objective on Sotera Health from $31.00 to $27.00 and set a buy rating for the company in a research report on Monday, March 21st. KeyCorp lowered their price objective on Sotera Health from $33.00 to $30.00 and set an overweight rating for the company in a research report on Wednesday, March 2nd. Finally, Credit Suisse Group decreased their target price on Sotera Health from $31.00 to $28.00 and set an outperform rating for the company in a research note on Wednesday, March 2nd. Two investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Sotera Health currently has an average rating of Buy and an average target price of $25.71.

Shares of NYSE SHC opened at $21.14 on Thursday. The firm has a market capitalization of $5.98 billion, a price-to-earnings ratio of 43.14 and a beta of 0.37. The company has a current ratio of 2.58, a quick ratio of 2.27 and a debt-to-equity ratio of 2.78. The firm has a 50 day moving average of $20.98 and a 200 day moving average of $21.41. Sotera Health has a 12-month low of $18.31 and a 12-month high of $27.38.

Sotera Health (NYSE:SHCGet Rating) last released its earnings results on Thursday, May 5th. The company reported $0.20 earnings per share for the quarter, beating the consensus estimate of $0.18 by $0.02. The company had revenue of $237.00 million during the quarter, compared to the consensus estimate of $229.40 million. Sotera Health had a return on equity of 42.65% and a net margin of 14.30%. Sotera Health’s revenue was up 11.8% compared to the same quarter last year. During the same period in the previous year, the company posted $0.13 EPS. Sell-side analysts predict that Sotera Health will post 0.93 EPS for the current year.

Hedge funds and other institutional investors have recently modified their holdings of the business. Joseph Group Capital Management purchased a new stake in Sotera Health in the fourth quarter valued at approximately $897,000. Spire Wealth Management lifted its stake in Sotera Health by 50.0% in the fourth quarter. Spire Wealth Management now owns 1,679 shares of the company’s stock valued at $40,000 after buying an additional 560 shares during the last quarter. Allworth Financial LP lifted its stake in Sotera Health by 133.3% in the fourth quarter. Allworth Financial LP now owns 3,150 shares of the company’s stock valued at $74,000 after buying an additional 1,800 shares during the last quarter. Mitsubishi UFJ Trust & Banking Corp purchased a new stake in Sotera Health in the third quarter valued at approximately $86,000. Finally, Ensign Peak Advisors Inc purchased a new stake in Sotera Health in the fourth quarter valued at approximately $122,000. Institutional investors own 87.44% of the company’s stock.

About Sotera Health (Get Rating)

Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries.

Read More

Get a free copy of the Zacks research report on Sotera Health (SHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Sotera Health (NYSE:SHC)

Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.